Quest Diagnostics 2013 Annual Report Download - page 117

Download and view the complete annual report

Please find page 117 of the 2013 Quest Diagnostics annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 131

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131

F- 45
finalized separate settlement agreements with certain states and paid approximately $6 million, which had been previously
reserved for.
Summarized financial information for the discontinued operations is set forth below:
2013 2012 2011
Net revenues $ 28 $ 117 $ 119
Income (loss) from discontinued operations before taxes 25 (74)7
Income tax expense (benefit) (10)— (5)
Income (loss) from discontinued operations, net of taxes $ 35 $ (74)$ 12
The following table summarizes the HemoCue assets and liabilities held for sale in the consolidated balance sheets at
December 31, 2012:
2012
Assets held for sale:
Cash and cash equivalents $17
Accounts receivable, net 15
Inventories 5
Prepaid expenses and other current assets 3
Total current assets held for sale 40
Property, plant and equipment, net 24
Goodwill 219
Intangible assets, net 111
Total non-current assets held for sale $ 354
Liabilities held for sale:
Accounts payable and accrued expenses $ 21
Current portion of long-term debt 1
Total current liabilities held for sale 22
Long-term debt 16
Other liabilities 44
Total non-current liabilities held for sale $ 60
Continuing cash flows from discontinued operations were not material.
The remaining balance sheet information related to NID and OralDNA was not material at December 31, 2013 and
2012. The remaining balance sheet information related to HemoCue was not material at December 31, 2013.
20. BUSINESS SEGMENT INFORMATION
The clinical testing that the Company performs is an essential element in the delivery of healthcare services.
Physicians use clinical testing to assist in detection, diagnosis, evaluation, monitoring and treatment of diseases and other
medical conditions.
QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED
(in millions unless otherwise indicated)